OJRA  Vol.5 No.2 , May 2015
Pathogenesis of Neuropsychiatric Syndromes of Systemic Lupus Erythematosus
The pathogenesis of neuropsychiatric syndromes of systemic lupus erythematosus (NPSLE) is multifactorial and can involve various inflammatory cytokines, autoantibodies such as anti-neuronal antibodies, anti-ribosomal P antibodies, anti-NR2 glutamate receptor binding antibodies, anti-Sm antibodies, anti-U1-RNP antibodies and anti-phospholipid antibodies, and immune complexes (IC). Disruption of the blood-brain barrier (BBB) is integral to the neuropathology of SLE. Recently the possibility has been reported that aforementioned autoantibodies in the circulation may be strongly associated with disruption of the BBB. Each of these mechanisms might contribute to the pathogenesis of focal NPSLE (for example, cerebrovascular disease, movement disorders, myelopathy, seizures and cranial neuropathy) or diffuse NPSLE (for example, acute confusional state, psychosis and cognitive dysfunction) to varying degrees. In this review we focus on how the aforementioned autoantibodies, the BBB, IC and cytokines as well as chemokines are associated with the appearance of NPSLE.

Cite this paper
Yoshio, T. and Okamoto, H. (2015) Pathogenesis of Neuropsychiatric Syndromes of Systemic Lupus Erythematosus. Open Journal of Rheumatology and Autoimmune Diseases, 5, 46-56. doi: 10.4236/ojra.2015.52009.

[1]   Belmont, H.M., Abramson, S.B. and Lie, J.T. (1996) Pathology and Pathogenesis of Vascular Injury in Systemic Lupus Erythematosus. Interactions of Inflammatory Cells and Activated Endothelium. Arthritis Rheumatology, 39, 9-22.

[2]   Hanly, J.G., Walsh, N.M. and Sangalang, V. (1992) Brain Pathology in Systemic Lupus Erythematosus. Journal of Rheumatology, 19, 732-741.

[3]   Abbott, N.J., Mendonca, L.L. and Dolman, D.E. (2003) The Blood-Brain Barrier in Systemic Lupus Erythematosus. Lupus, 12, 908-915.

[4]   Devreese, K.M. (2012) Standardization of Antiphospholipid Antibody Assays. Where Do We Stand? Lupus, 21, 718-721.

[5]   Kent, M., Alvarez, F., Vogt, E., Fyffe, R., Ng, A.K. and Rote, N. (1997) Monoclonal Antiphosphatidylserine Antibodies React Directly with Feline and Murine Central Nervous System. Journal of Rheumatology, 24, 1725-1733.

[6]   Shoenfeld, Y., Nahum, A., Korczyn, A.D., Dano, M., Rabinowitz, R., Beilin, O., et al. (2003) Neuronal-Binding Antibodies from Patients with Antiphospholipid Syndrome Induce Cognitive Deficits Following Intrathecal Passive Transfer. Lupus, 12, 436-442.

[7]   Caronti, B., Calderaro, C., Alessandri, C., Conti, F., Tinghino, R., Pini, C., et al. (1998) Serum Anti-Beta2-Glycoprotein I Antibodies from Patients with Antiphospholipid Antibody Syndrome Bind Central Nervous System Cells. Journal of Autoimmunity, 11, 425-429.

[8]   Caronti, B., Pittoni, V., Palladini, G. and Valesini, G. (1998) Anti-Beta 2-Glycoprotein I Antibodies Bind to Central Nervous System. Journal of Neuroscience, 156, 211-219.

[9]   Denburg, S.D., Carbotte, R.M. and Denburg, J.A. (1987) Cognitive Impairment in Systemic Lupus Erythematosus: A Neuropsychological Study of Individual and Group Deficits. Journal of Clinical and Experimental Neuropsychology, 9, 323-339.

[10]   Hanly, J.G., Robichaud, J. and Fisk, J.D. (2006) Anti-NR2 Glutamate Receptor Antibodies and Cognitive Function in Systemic Lupus Erythematosus. Journal of Rheumatology, 33, 1553-1558.

[11]   Cervera, R., Khamashta, M.A., Font, J., Sebastiani, G.D., Gil, A., Lavilla, P., et al. (2003) Morbidity and Mortality in Systemic Lupus Erythematosus during a 10-Year Period: A Comparison of Early and Late Manifestations in a Cohort of 1, 000 Patients. Medicine, 82, 299-308.

[12]   Hanly, J.G., Hong, C., Smith, S. and Fisk, J.D. (1999) A Prospective Analysis of Cognitive Function and Anticardiolipin Antibodies in Systemic Lupus Erythematosus. Arthritis & Rheumatism, 42, 728-734.

[13]   Menon, S., Jameson-Shortall, E., Newman, S.P., Hall-Craggs, M.R., Chinn, R. and Isenberg, D.A. (1999) A Longitudinal Study of Anticardiolipin Antibody Levels and Cognitive Functioning in Systemic Lupus Erythematosus. Arthritis & Rheumatism, 42, 735-741.

[14]   Shah, N.M., Khamashta, M.A., Atsumi, T. and Hughes, G.R. (1998) Outcome of Patients with Anticardiolipin Antibodies: A 10 Year Follow-Up of 52 Patients. Lupus, 7, 3-6.

[15]   Toubi, E., Khamashta, M.A., Panarra, A. and Hughes, G.R. (1995) Association of Antiphospholipid Antibodies with Central Nervous System Disease in Systemic Lupus Erythematosus. The American Journal of Medicine, 99, 397-401.

[16]   Rodriguez, A.S., Oterino, J.A. and Hernandez, P.A. (1998) Lupus Myelitis. Archives of Internal Medicine, 158, 2267-2268.

[17]   Borowoy, A.M., Pope, J.E., Silverman, E., Fortin, P.R., Pineau, C., Smith, C.D., et al. (2012) Neuropsychiatric Lupus: The Prevalence and Autoantibody Associations Depend on the Definition: Results from the 1000 Faces of Lupus Cohort. Seminars in Arthritis and Rheumatism, 42, 179-185.

[18]   Bluestein, H.G., Williams, G.W. and Steinberg, A.D. (1981) Cerebrospinal Fluid Antibodies to Neuronal Cells: Association with Neuropsychiatric Manifestations of Systemic Lupus Erythematosus. The American Journal of Medicine, 70, 240-246.

[19]   Isshi, K. and Hirohata, S. (1998) Differential Roles of the Anti-Ribosomal P Antibody and Antineuronal Antibody in the Pathogenesis of Central Nervous System Involvement in Systemic Lupus Erythematosus. Arthritis & Rheumatism, 41, 1819-1827.

[20]   Winfield, J.B., Brunner, C.M. and Koffler, D. (1978) Serologic Studies in Patients with Systemic Lupus Erythematosus and Central Nervous System Dysfunction. Arthritis & Rheumatism, 21, 289-294.

[21]   Yasuma, M., Takasaki, Y., Matsumoto, K., Kodama, A., Hashimoto, H. and Hirose, S. (1990) Clinical Significance of IgG Anti-Sm Antibodies in Patients with Systemic Lupus Erythematosus. The Journal of Rheumatology, 17, 469-475.

[22]   Hirohata, S. and Kosaka, M. (1994) Association of Anti-Sm Antibodies with Organic Brain Syndrome Secondary to Systemic Lupus Erythematosus. The Lancet, 343, 796.

[23]   Hirohata, S., Sakuma, Y., Yanagida, T. and Yoshio, T. (2014) Association of Cerebrospinal Fluid Anti-Sm Antibodies with Acute Confusional State in Systemic Lupus Erythematosus. Arthritis Research & Therapy, 16, 450.

[24]   Sato, T., Fujii, T., Yokoyama, T., Fujita, Y., Imura, Y., Yukawa, N., et al. (2010) Anti-U1 RNP Antibodies in Cerebrospinal Fluid Are Associated with Central Neuropsychiatric Manifestations in Systemic Lupus Erythematosus and Mixed Connective Tissue Disease. Arthritis Research & Therapy, 62, 3730-3740.

[25]   Santer, D.M., Yoshio, T., Minota, S., Moller, T. and Elkon, K.B. (2009) Potent Induction of IFN-α and Chemokines by Autoantibodies in the Cerebrospinal Fluid of Patients with Neuropsychiatric Lupus. The Journal of Immunology, 182, 1192-1201.

[26]   Furukawa, H., Singh, S.K., Mancusso, R. and Gouaux, E. (2005) Subunit Arrangement and Function in NMDA Receptors. Nature, 438, 185-192.

[27]   De Giorgio, L.A., Konstantinov, K.N., Lee, S.C., Hardin, J.A., Volpe, B.T. and Diamond, B. (2001) A Subset of Lupus Anti-DNA Antibodies Cross-Reacts with the NR2 Glutamate Receptor in Systemic Lupus Erythematosus. Nature Medicine, 7, 1189-1193.

[28]   Kowal, C., De Giorgio, L.A., Nakaoka, T., Hetherington, H., Huerta, P.T., Diamond, B., Volpe, B.T., et al. (2004) Cognition and Immunity: Antibody Impairs Memory. Immunity, 21, 179-188.

[29]   Husebye, E.S., Sthoeger, Z.M., Dayan, M., Zinger, H., Elbirt, D., Levite, M., et al. (2005) Autoantibodies to a NR2A Peptide of the Glutamate/NMDA Receptor in Sera of Patients with Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases, 64, 1210-1213.

[30]   Omdal, R., Brokstad, K., Waterloo, K., Koldingsnes, W., Jonsson, R. and Mellgren, S.I. (2005) Neuropsychiatric Disturbances in SLE Are Associated with Antibodies Against NMDA Receptors. European Journal of Neurology, 12, 392-398.

[31]   Yoshio, T., Onda, K., Nara, H. and Minota, S. (2006) Association of IgG Anti-NR2 Glutamate Receptor Antibodies in Cerebrospinal Fluid with Neuropsychiatric Systemic Lupus Erythematosus. Arthritis & Rheumatism, 54, 675-678.

[32]   Arinuma, Y., Yanagida, T. and Hirohata, S. (2008) Association of Cerebrospinal Fluid Anti-NR2 Glutamate Receptor Antibodies with Diffuse Neuropsychiatric Systemic Lupus Erythematosus. Arthritis & Rheumatism, 58, 1130-1135.

[33]   Nojima, Y., Minota, S., Yamda, A., Takaku, F., Aotsuka, S. and Yokohari, R. (1992) Correlation of Antibodies to Ribosomal P Protein with Psychosis in Patients with Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases, 51, 1053-1055.

[34]   Schneebaum, A.B., Singleton, J.D., West, S.G., Blodgett, J.K., Allen, L.G., Cheronis, J.C., et al. (1991) Association of Psychiatric Manifestations with Antibodies to Ribosomal P Proteins in Systemic Lupus Erythematosus. The American Journal of Medicine, 90, 54-62.

[35]   Teh, L.S., Bedwell, A.E., Isenberg, D.A., Gordon, C., Emery, P., Charles, P.J., et al. (1992) Antibodies to Protein P in Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases, 51, 489-494.

[36]   Georgescu, L., Mevorach, D., Arnett, F.C., Reveille, J.D. and Elkon, K.B. (1997) Anti-P Antibodies and Neuropsychiatric Lupus Erythematosus. Annals of the New York Academy of Sciences, 823, 263-269.

[37]   Karassa, F.B., Afeltra, A., Ambrozic, A., Chang, D.M., De Keyser, F., Doria, A., et al. (2006) Accuracy of Anti-Ribosomal P Protein Antibody Testing for the Diagnosis of Neuropsychiatric Systemic Lupus Erythematosus: An International Meta-Analysis. Arthritis & Rheumatism, 54, 312-314.

[38]   Katzav, A., Solodeev, I., Brodsky, O., Chapman, J., Pick, C.G., Blank, M., et al. (2007) Induction of Autoimmune Depression in Mice by Anti-Ribosomal P Antibodies via the Limbicsystem. Arthritis & Rheumatism, 56, 938-948.

[39]   Matus, S., Burgos, P.V., Bravo-Zehnder, M., Kraft, R., Porras, O.H., Farías, P., et al. (2007) Antiribosomal-P Autoantibodies from Psychiatric Lupus Target a Novel Neuronal Surface Protein Causing Calcium Influx and Apoptosis. The Journal of Experimental Medicine, 204, 3221-3234.

[40]   Bravo-Zehnder, M., Toledo, E.M., Segovia-Miranda, F., Serrano, F.G., Benito, M.J., Metz, C., et al. (2015) Anti-Ribosomal P Protein Autoantibodies from Neuropsychiatric Lupus Impair Memory. Arthritis & Rheumatology, 67, 204-214.

[41]   Yoshio, T., Hirata, D., Onda, K., Nara, H. and Minota, S. (2005) Antiribosomal P Protein Antibodies in Cerebrospinal Fluid Are Associated with Neuropsychiatric Systemic Lupus Erythematosus. The Journal of Rheumatology, 32, 34-39.

[42]   Williams Jr., R.C., Sugiura, K. and Tan, E.M. (2004) Antibodies to Microtubule-Associated Protein 2 in Patients with Neuropsychiatric Systemic Lupus Erythematosus. Arthritis & Rheumatism, 50, 1239-1247.

[43]   Lefranc, D., Launay, D., Dubucquoi, S., de Seze, J., Dussart, P., Vermersch, M., et al. (2007) Characterization of Discriminant Human Brain Antigenic Targets in Neuropsychiatric Systemic Lupus Erythematosus Using an Immunoproteomic Approach. Arthritis & Rheumatism, 56, 3420-3432.

[44]   Yoshio, T., Okamoto, H., Hirohata, S. and Minota, S. (2013) IgG Anti-NR2 Glutamate Receptor Autoantibodies from Patients with Systemic Lupus Erythematosus Activate Endothelial Cells. Arthritis & Rheumatism, 65, 457-463.

[45]   Conti, F., Alessandri, C., Bompane, D., Bombardieri, M., Spinelli, F.R., Rusconi, A.C., et al. (2004) Autoantibody Profile in Systemic Lupus Erythematosus with Psychiatric Manifestations: A Role for Anti-Endothelial-Cell Antibodies. Arthritis Research & Therapy, 6, R366-R372.

[46]   Oosting, J.D., Preissner, K.T., Derksen, R.H. and de Groot, P.G. (1993) Autoantibodies Directed Against the Epidermal Growth Factor-Like Domains of Thrombomodulin Inhibit Protein C Activation in Vitro. British Journal of Haematology, 85, 761-768.

[47]   Nara, H., Okamoto, H., Minota, S. and Yoshio, T. (2006) Mouse Monoclonal Anti-Human Thrombomodulin Antibodies Bind to and Activate Endothelial Cells Through NF-κB Activation in Vitro. Arthritis & Rheumatism, 54, 1629-1637.

[48]   Wong, D., Dorovini-Zis, K. and Vincent, S.R. (2004) Cytokines, Nitric Oxide, and cGMP Modulate the Permeability of an in Vitro Model of the Human Blood-Brain Barrier. Experimental Neurology, 190, 446-455.

[49]   Shiozawa, S., Kuoroki, Y., Kim, M., Hirohata, S. and Ogino, T. (1992) Interferon-Alpha in Lupus Psychosis. Arthritis & Rheumatism, 35, 417-422.

[50]   Lovgren, T., Eloranta, M.L., Bave, U., Alm, G.V. and Ronnblom, L. (2004) Induction of Interferon-Production in Plasmacytoid Dendritic Cells by Immune Complexes Containing Nucleic Acid Released by Necrotic or Late Apoptotic Cells and Lupus IgG. Arthritis & Rheumatism, 50, 1861-1872.

[51]   Martin, D.A. and Elkon, K.B. (2005) Autoantibodies Make a U-Turn: The Toll Hypothesis for Autoantibody Specificity. The Journal of Experimental Medicine, 202, 1465-1469.

[52]   Marshak-Rothstein, A. and Rifkin, I.R. (2007) Immunologically Active Autoantigens: The Role of Toll-Like Receptors in the Development of Chronic Inflammatory Disease. Annual Review of Immunology, 25, 419-441.

[53]   Yoshio, T., Okamoto, H., Kurasawa, K., Dei, Y., Hirohata, S. and Minota, S. (2013) The Presence of IgG-Immune Complexes in the Cerebrospinal Fluids Is Associated with Central Neurocychiatricmanifestatin but Not with Intrathecal Production of Proimmflammatory Cytokines/Chemokines Such as Interferon-α in Systemic Lupus Erythematosus. Arthritis & Rheumatism, 65, S1593.

[54]   Trysberg, E., Carlsten, H. and Tarkowski, A. (2000) Intrathecal Cytokines in Systemic Lupus Erythematosus with Central Nervous System Involvement. Lupus, 9, 498-503.

[55]   Svenungsson, E., Andersson, M., Brundin, L.,van Vollenhoven, R., Khademi, M., Tarkowski, A., et al. (2001) Increased Levels of Proinflammatory Cytokines and Nitric Oxide Metabolites in Neuropsychiatric Lupus Erythematosus. Annals of the Rheumatic Diseases, 60, 372-379.

[56]   Iikuni, N., Okamoto, H., Yoshio, T., Sato, E., Kamitsuji, S., Iwamoto, T., et al. (2006) Raised Monocyte Chemotactic Protein-1 (MCP-1)/CCL2 in Cerebrospinal Fluid of Patients with Neuropsychiatric Lupus. Annals of the Rheumatic Diseases, 65, 253-256.

[57]   Okamoto, H., Iikuni, N., Kamitsuji, S., Yoshio, T., Minota, S. and Kamatani, N. (2006) IP-10/MCP-1 Ratio in CSF Is an Useful Diagnostic Marker of Neuropsychiatric Lupus Patients. Rheumatology, 45, 232-234.

[58]   Okamoto, H., Katsumata, Y., Nishimura, K. and Kamatani, N. (2004) Interferon-Inducible Protein 10/CXCL10 Is Increased in the Cerebrospinal Fluid of Patients with Central Nervous System Lupus. Arthritis & Rheumatism, 50, 3731-3732.

[59]   Yoshio, T., Okamoto, H., Kurasawa, K., Dei, Y., Hirohata, S. and Minota, S. (2011) The Intrathecal Production of IL-6, IL-8, IP-10, MCP-1 and G-CSF Increases More Highly Than the Serum Production in Patients with Central Neuropsychiatric Lupus Erythematosus. Arthritis & Rheumatism, 63, S1711.

[60]   Matsushita, T., Tateishi, T., Isobe, N., Yonekawa, T., Yamasaki, R., Matsuse, D., et al. (2013) Characteristic Cerebrospinal Fluid Cytokine/Chemokine Profiles in Neuromyelitisoptica, Relapsing Remitting or Primary Progressive Multiple Sclerosis. PLoS ONE, 8, e61835.

[61]   Schneider, A., Kruger, C., Steigleder, T., Weber, D., Pitzer, C., Laage, R., et al. (2005) The Hematopoietic Factor G-CSF Is a Neuronal Ligand That Counteracts Programmed Cell Death and Drives Neurogenesis. The Journal of Clinical Investigation, 115, 2083-2098.

[62]   Pitzer, C., Krüger, C., Plaas, C., Kirsch, F., Dittgen, T., Müller, R., et al. (2008) Granulocyte-Colony Stimulating Factor Improves Outcome in a Mouse Model of Amyotrophic Lateral Sclerosis. Brain, 131, 3335-3347.

[63]   Hirohata, S., Arinuma, Y., Takayama, M. and Yoshio, T. (2007) Association of Cerebrospinal Fluid Anti-Ribosomal P Protein Antibodies with Diffuse Psychiatric/Neuropsychological Syndromes in Systemic Lupus Erythematosus. Arthritis Research & Therapy, 9, R44.

[64]   Fancellu, R., Pareyson, D., Corsini, E., Salsano, E., Laura?, M., Bernardi, G., et al. (2009) Immunological Reactivity against Neuronal and Non-Neuronal Antigens in Sporadic Adult-Onset Cerebellar Ataxia. European Neurology, 62, 356-361.

[65]   Disanto, G., Morahan, J.M., Barnett, M.H., Giovannoni, G. and Ramagopalan, S.V. (2012) Theevidence for a Role of B Cells in Multiple Sclerosis. Neurology, 78, 823-832.